Peptide therapeutics in pharmaceutical landscape is evolving rapidly. It is driven by advancements in synthesis technologies, analytical characterization, and scalable manufacturing processes. This presentation will explore innovative strategies to improve process efficiencies and overcome challenges in peptide manufacturing, including solid-phase synthesis, liquid-phase synthesis, purification, and isolation. Integrating analytical techniques for in-process monitoring and quality control ensures product consistency and regulatory compliance. Case studies highlighting successful manufacturing scale-up, process optimization, and novel technologies in peptide CMC (Chemistry, Manufacturing, and Controls) will be discussed to provide a comprehensive overview of best practices to accelerate therapeutic development of peptides from lab to market.